Univ Of Iowa Hospitals And Clinics
Welcome,         Profile    Billing    Logout  
 3 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Martinez, Francisco E
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)

Recruiting
2
320
Europe, Canada, Japan, US, RoW
TIN816 70 mg lyophilisate powder, Placebo
Novartis Pharmaceuticals
Acute Kidney Injury Due to Sepsis
12/25
02/26
Wunderink, Richard
REPAVID-22, NCT05254990 / 2021-006951-32: Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

Terminated
3
409
Europe, US, RoW
Reparixin, Repertaxin L-lysine salt, Placebo, Matched placebo
Dompé Farmaceutici S.p.A
Infectious Pneumonia, Severe COVID-19
09/24
09/24
I-SPY_COVID, NCT04488081: I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Recruiting
2
1500
US
Remdesivir, GS-5734, Imatinib Mesylate, Dexamethasone, Cenicriviroc, Icatibant, Firazyr, Apremilast, Otezla, dornase alfa, Pulmozyme, Celecoxib, celebrex, Famotidine, Pepcid, IC14, Aviptadil, Zyesami, narsoplimab, OMS721, Cyproheptadine, periactin, Cyclosporine, CsA
QuantumLeap Healthcare Collaborative, University of California, San Francisco, University of Pennsylvania, Emory University, University of Alabama at Birmingham, University of Colorado, Denver, University of Southern California, Yale University, Wake Forest University Health Sciences, Sanford Health, Long Beach Memorial Medical Center, Georgetown University, University of California, Davis, Hoag Memorial Hospital Presbyterian, Main Line Health, DHR Health Institute for Research and Development, University of California, Irvine, Corewell Health, Kaiser Permanente, University of Michigan, West Virginia University, University of Miami, University Hospitals Cleveland Medical Center, Virtua Health, M.D. Anderson Cancer Center
COVID-19
07/28
07/30
NCT05947955: Rhu-pGSN for Acute Respiratory Distress Syndrome (ARDS)

Recruiting
2
600
Europe, US
Rhu-pGSN, recombinant human gelsolin, normal saline, 0.9% sterile saline
BioAegis Therapeutics Inc., Biomedical Advanced Research and Development Authority
Acute Respiratory Distress Syndrome, Infections
10/26
03/27
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)

Recruiting
2
320
Europe, Canada, Japan, US, RoW
TIN816 70 mg lyophilisate powder, Placebo
Novartis Pharmaceuticals
Acute Kidney Injury Due to Sepsis
12/25
02/26
RESCUE3, NCT03783884: A Protocol Comparing Temporary Transvenous Diaphragm Pacing to Standard of Care for Weaning From Mechanical Ventilation

Terminated
N/A
223
Europe, US
Lungpacer Diaphragm Pacing Therapy, Lungpacer DPTS, AeroPace System
Lungpacer Medical Inc.
Ventilator Induced Diaphragm Dysfunction
12/22
01/23
NCT04105699: Evaluation of Immunoassay Measurements of Pancreatic Stone Protein Performed on abioSCOPE® Device With the PSP Assay on ICU Patients at Risk of Sepsis as an Aid in Identifying Sepsis

Completed
N/A
544
US
Blood sampling
Abionic SA, Avania
Sepsis
08/23
12/23
Gee, Kayla Mc
NCT05996835: Phase 2b Study to Investigate the Safety and Efficacy of TIN816 in Sepsis-associated Acute Kidney Injury (SA-AKI)

Recruiting
2
320
Europe, Canada, Japan, US, RoW
TIN816 70 mg lyophilisate powder, Placebo
Novartis Pharmaceuticals
Acute Kidney Injury Due to Sepsis
12/25
02/26

Download Options